Labeler
Teva Pharmaceuticals USA, Inc. NDC Codes
Teva Pharmaceuticals USA, Inc. lists 486 finished drug products in the FDA NDC Directory under NDC labeler codes 0093, 0172, 0480, 0555, 50111, 51759.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Uzedy, Simlandi, Clonazepam, Adalimumab-ryvk, Ustekinumab-aekn, Everolimus, Sunitinib Malate, Trazodone Hydrochloride, Cyclobenzaprine Hydrochloride, Selarsdi, Carbidopa and levodopa, Lanthanum carbonate, fluticasone propionate and salmeterol, Lorazepam, Erlotinib
- Active ingredients
- Ustekinumab-aekn, Risperidone, Clonazepam, Hydrochlorothiazide, Everolimus, Sunitinib malate, Trazodone hydrochloride, Cyclobenzaprine hydrochloride, Carbidopa hydrate, Levodopa, Lanthanum carbonate, Fluticasone propionate
- NDC labeler codes
- 0093, 0172, 0480, 0555, 50111, 51759
- Strengths (from the 100 most recently listed products)
- Ustekinumab-aekn 45 mg/.5mL; Ustekinumab-aekn 90 mg/mL; Salmeterol xinafoate 50 ug/1; Hydrochlorothiazide 6.25 mg/1; Carbidopa hydrate 25 mg/1; Levodopa 100 mg/1; Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1; Hydrochlorothiazide 12.5 mg/1; Eculizumab 300 mg/30mL; Ustekinumab-aekn 130 mg/26mL; Tramadol hydrochloride 50 mg/1; Liraglutide 6 mg/mL; Teriparatide acetate 250 ug/mL; Levodopa 250 mg/1; Everolimus 10 mg/1; Risperidone 50 mg/.14mL; Risperidone 75 mg/.21mL; Risperidone 100 mg/.28mL; Risperidone 125 mg/.35mL
- Dosage forms
- Tablet, Tablet, Film coated, Kit, Injection, Solution, Injection, Suspension, Extended release, Tablet, Orally disintegrating, Cream, Capsule, Injection, Tablet, Chewable, Powder, Capsule, Liquid filled, Capsule, Extended release, Patch, Extended release, Solution, Tablet, Sugar coated, Insert, Extended release, System, Powder, For suspension, Capsule, Delayed release
- Routes
- Oral, Subcutaneous, Topical, Respiratory (Inhalation), Intravenous, Transdermal, Vaginal, Intramuscular
- Drug classes (FDA established)
- Kinase Inhibitor, Atypical Antipsychotic, Benzodiazepine, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Thiazide Diuretic, mTOR Inhibitor Immunosuppressant, beta2-Adrenergic Agonist, Serotonin Reuptake Inhibitor, Muscle Relaxant, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Aromatic Amino Acid, Aminosalicylate, Phosphate Binder, Corticosteroid, Calcineurin Inhibitor Immunosuppressant, l-Triiodothyronine, beta-Adrenergic Blocker, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Macrolide Antimicrobial, Macrolide, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Complement Inhibitor, Opioid Agonist, GLP-1 Receptor Agonist, Parathyroid Hormone Analog, Tricyclic Antidepressant, Partial Opioid Agonist, Reducing and Complexing Thiol, Estrogen, Progestin, Antimalarial, Antirheumatic Agent, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Bradykinin B2 Receptor Antagonist, Neuraminidase Inhibitor, Ergot Derivative
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 143 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Adalimumab-ryvk | — | Kit | 51759-310 | 51759-0310-59 | — |
| Adalimumab-ryvk | — | Kit | 51759-311 | 51759-0311-58 | — |
| Ustekinumab-aekn | Ustekinumab-aekn 45 mg/.5mL | Injection, SolutionSubcutaneous | 51759-413 | 51759-0413-32 | — |
| Ustekinumab-aekn | Ustekinumab-aekn 90 mg/mL | Injection, SolutionSubcutaneous | 51759-414 | 51759-0414-32 | — |
| Adalimumab-ryvk | — | Kit | 51759-360 | 51759-0360-02 | — |
| Adalimumab-ryvk | — | Kit | 51759-361 | 51759-0361-17 | — |
| Hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | TabletOral | 0172-3444 | 00172-3444-6000172-3444-80 | — |
| Ustekinumab-aekn | Ustekinumab-aekn 45 mg/.5mL | Injection, SolutionSubcutaneous | 51759-709 | 51759-0709-32 | — |
| Ustekinumab-aekn | Ustekinumab-aekn 90 mg/mL | Injection, SolutionSubcutaneous | 51759-710 | 51759-0710-32 | — |
| Epysqlieculizumab-aagh | Eculizumab 300 mg/30mL | Injection, SolutionIntravenous | 51759-208 | 51759-0208-13 | — |
| Selarsdiustekinumab-aekn | Ustekinumab-aekn 45 mg/.5mL | Injection, SolutionSubcutaneous | 51759-505 | 51759-0505-1351759-0505-32 | — |
| Selarsdiustekinumab-aekn | Ustekinumab-aekn 90 mg/mL | Injection, SolutionSubcutaneous | 51759-607 | 51759-0607-32 | — |
| Selarsdiustekinumab-aekn | Ustekinumab-aekn 130 mg/26mL | Injection, SolutionIntravenous | 51759-708 | 51759-0708-13 | — |
| Simlandiadalimumab-ryvk | — | KitSubcutaneous | 51759-274 | 51759-0274-17 | — |
| Simlandiadalimumab-ryvk | — | Kit | 51759-386 | 51759-0386-22 | — |
| Simlandiadalimumab-ryvk | — | Kit | 51759-523 | 51759-0523-21 | — |
| Simlandiadalimumab-ryvk | — | Kit | 51759-412 | 51759-0412-22 | — |
| Tramadol Hydrochloride | Tramadol hydrochloride 50 mg/1 | Tablet, Film coatedOral | 0093-3301 | 00093-3301-0100093-3301-05 | — |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | 0480-3667 | 00480-3667-2000480-3667-22 | — |
| Simlandiadalimumab-ryvk | — | KitSubcutaneous | 51759-402 | 51759-0402-0251759-0402-17 | — |
| Teriparatide | Teriparatide acetate 250 ug/mL | Injection, SolutionSubcutaneous | 0093-1106 | 00093-1106-16 | — |
| Carbidopa and levodopa | Carbidopa hydrate 25 mg/1; Levodopa 250 mg/1 | TabletOral | 0093-9703 | 00093-9703-0100093-9703-0500093-9703-10 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | 0093-7769 | 00093-7769-24 | — |
| Uzedyrisperidone | Risperidone 50 mg/.14mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-305 | 51759-0305-1051759-0305-11 | — |
| Uzedyrisperidone | Risperidone 75 mg/.21mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-410 | 51759-0410-1051759-0410-11 | — |
| Uzedyrisperidone | Risperidone 100 mg/.28mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-520 | 51759-0520-1051759-0520-11 | — |
| Uzedyrisperidone | Risperidone 125 mg/.35mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-630 | 51759-0630-1051759-0630-11 | — |
| Uzedyrisperidone | Risperidone 150 mg/.42mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-740 | 51759-0740-1051759-0740-11 | — |
| Uzedyrisperidone | Risperidone 200 mg/.56mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-850 | 51759-0850-1051759-0850-11 | — |
| Uzedyrisperidone | Risperidone 250 mg/.7mL | Injection, Suspension, Extended releaseSubcutaneous | 51759-960 | 51759-0960-1051759-0960-11 | — |
| doxepin hydrochloride | Doxepin hydrochloride 50 mg/g | CreamTopical | 0093-9609 | 00093-9609-95 | — |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | 0093-3234 | 00093-3234-0100093-3234-0500093-3234-10 | — |
| Penciclovir | Penciclovir 10 mg/g | CreamTopical | 0093-3186 | 00093-3186-20 | — |
| Finzalanorethindrone acetate and ethinyl estradiol and ferrous fumarate | — | Kit | 0093-8210 | 00093-8210-62 | — |
| Lanthanum carbonate | Lanthanum carbonate 500 mg/1 | Tablet, ChewableOral | 0093-5938 | 00093-5938-98 | — |
| Lanthanum carbonate | Lanthanum carbonate 750 mg/1 | Tablet, ChewableOral | 0093-5939 | 00093-5939-98 | — |
| Lanthanum carbonate | Lanthanum carbonate 1000 mg/1 | Tablet, ChewableOral | 0093-5940 | 00093-5940-98 | — |
| fluticasone propionate and salmeterol | Fluticasone propionate 250 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 0093-7518 | 00093-7518-31 | — |
| fluticasone propionate and salmeterol | Fluticasone propionate 500 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 0093-7516 | 00093-7516-31 | — |
| fluticasone propionate and salmeterol | Fluticasone propionate 100 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 0093-7517 | 00093-7517-31 | — |
| Clonazepam | Clonazepam .125 mg/1 | Tablet, Orally disintegratingOral | 0093-9290 | 00093-9290-67 | — |
| Clonazepam | Clonazepam .25 mg/1 | Tablet, Orally disintegratingOral | 0093-9291 | 00093-9291-67 | — |
| Clonazepam | Clonazepam .5 mg/1 | Tablet, Orally disintegratingOral | 0093-9292 | 00093-9292-67 | — |
| Clonazepam | Clonazepam 2 mg/1 | Tablet, Orally disintegratingOral | 0093-9294 | 00093-9294-67 | — |
| Carbidopa and levodopa | Carbidopa hydrate 10 mg/1; Levodopa 100 mg/1 | TabletOral | 0093-9701 | 00093-9701-0100093-9701-05 | — |
| Carbidopa and levodopa | Carbidopa hydrate 25 mg/1; Levodopa 100 mg/1 | TabletOral | 0093-9702 | 00093-9702-0100093-9702-0500093-9702-10 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | 0093-3239 | 00093-3239-40 | — |
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | 0093-8199 | 00093-8199-28 | — |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | 0093-8224 | 00093-8224-28 | — |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | 0093-8229 | 00093-8229-28 | — |
Teva Pharmaceuticals USA, Inc.: common questions
- What is Teva Pharmaceuticals USA, Inc.'s NDC labeler code?
- 0093, 0172, 0480, 0555, 50111, 51759. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Teva Pharmaceuticals USA, Inc.?
- Med-Code's HCPCS directory matches J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.